Evidence map›Paper›PMID 32251373›Full record

ArticleNature genetics2020

Spt5-mediated enhancer transcription directly couples enhancer activation with physical promoter interaction.

Johanna Fitz, Tobias Neumann, Monika Steininger, Eva-Maria Wiedemann, Adriana Cantoran Garcia, Alexander Athanasiadis, Ursula E Schoeberl, Rushad Pavri

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Johanna FitzResearch Institute of Molecular Pathology (IMP), Vienna, Austria.
Tobias NeumannResearch Institute of Molecular Pathology (IMP), Vienna, Austria.ORCID http://orcid.org/0000-0003-3908-4224
Monika SteiningerResearch Institute of Molecular Pathology (IMP), Vienna, Austria.
Eva-Maria WiedemannResearch Institute of Molecular Pathology (IMP), Vienna, Austria.
Adriana Cantoran GarciaResearch Institute of Molecular Pathology (IMP), Vienna, Austria.
Alexander AthanasiadisResearch Institute of Molecular Pathology (IMP), Vienna, Austria.
Ursula E SchoeberlResearch Institute of Molecular Pathology (IMP), Vienna, Austria.
Rushad PavriResearch Institute of Molecular Pathology (IMP), Vienna, Austria. pavri@imp.ac.at.ORCID http://orcid.org/0000-0002-6191-6333
Research Institute of Molecular Pathology · AT

Funding

Austrian Science Fund FWF P 29163Austrian Science Fund FWF P 32043Austrian Science Fund FWF T 795
6 · The paper itself

Abstract

Active enhancers are frequently transcribed, yet the regulatory role of enhancer transcription remains debated. Here, we depleted the RNA polymerase II pausing and elongation factor Spt5 in activated mouse B cells and found that approximately 50% of enhancer-gene pairs showed co-regulated transcription, consistent with a potential functional requirement for enhancer transcription. In particular, Spt5 depletion led to loss of super-enhancer-promoter physical interaction and gene expression at the immunoglobulin heavy-chain locus (Igh), abrogating antibody class switch recombination. This defect correlated strictly with loss of enhancer transcription but did not affect acetylation of histone H3 at lysine 27, chromatin accessibility and occupancy of Mediator and cohesin at the enhancer. Strikingly, CRISPRa-mediated rescue of enhancer transcription in Spt5-depleted cells restored Igh gene expression. Our work suggests that Spt5-mediated enhancer transcription underlies the physical and functional interaction between a subset of active enhancers and their target promoters.

Indexed as

AcetylationAnimalsCell Cycle ProteinsChromatinChromatin Assembly and DisassemblyChromosomal Proteins, Non-HistoneCohesinsEnhancer Elements, GeneticGene ExpressionGene RearrangementImmunoglobulin Class SwitchingMiceMice, Inbred C57BLMice, TransgenicNuclear ProteinsPromoter Regions, GeneticCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneCohesinsNuclear Proteins

Identifiers

PMID32251373
OpenAlexW3014787543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.